Literature DB >> 4919150

Erythromycin.

R S Griffith, H R Black.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4919150

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


× No keyword cloud information.
  8 in total

Review 1.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

2.  Hepatotoxicity of erythromycin estolate during pregnancy.

Authors:  W M McCormack; H George; A Donner; L F Kodgis; S Alpert; E W Lowe; E H Kass
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

3.  [Tissue penetration of erythromycin (author's transl)].

Authors:  G A Dette
Journal:  Infection       Date:  1979       Impact factor: 3.553

Review 4.  Erythromycin and the gut.

Authors:  S M Catnach; P D Fairclough
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

5.  Erythromycin ethyl succinate: diffusion through interstitial dermal fluid.

Authors:  L Vaillant; G Lorette; J Loulergue; A Audurier
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Toward a global picture of bacterial secondary metabolism.

Authors:  Mohammad R Seyedsayamdost
Journal:  J Ind Microbiol Biotechnol       Date:  2019-01-25       Impact factor: 3.346

7.  7-Chlorolincomycin therapy of pulmonary infections due to Myoplasma pneumoniae.

Authors:  J Axelrod; B R Meyers; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

8.  Failure of large-dose erythromycin in combination with a standard dose of chloroquine or quinine in the treatment of human falciparum malaria.

Authors:  L W Pang; E F Boudreau; G E Childs; H K Webster; C Supanantalerk; P Somutsakorn
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.